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Objective: The purpose of this study was to show the effects of the tracheal gas
insufflation (TGI) technique on gas exchange using helium-oxygen mixtures during
high-frequency oscillatory ventilation (HFOV). We hypothesized that a helium-oxygen
mixture delivered into the trachea using the TGI technique (0.3 L/min) would
enhance gas exchange during HFOV.
Methods: Three rabbits were prepared and ventilated by HFOV with carrier 70%
helium/oxygen or 70% nitrogen/oxygen gas mixture with TGI in a crossover study.
Changing the gas mixture from nitrogen70% to helium70% and back was performed
three times per animal with constant ventilation parameters.
Results: Compared with the nitrogen-oxygen mixture, the helium-oxygen mixture
of TGI reduced PaCO2 by 7.6 mmHg (p < 0.01) and improved PaO2 by 14 mmHg
(p < 0.01). Amplitude during TGI was significantly lower with the helium-oxygen
mixture than with the nitrogen-oxygen mixture (p < 0.01) and did not significantly
affect mean airway pressure.
Conclusions: This study demonstrated that a helium-oxygen mixture delivered into
the trachea using the TGI technique would enhance CO2 elimination and improve
oxygenation during HFOV.Background
In spite of advances in approach and therapeutic benefits of conventional mechanical
ventilation in respiratory failure in the neonatal intensive care unit (NICU), ventilator-
induced lung injury remains a major problem. This is particularly relevant in patients
who need aggressive maintenance of pressures and FiO2 for adequate oxygenation. In
such patients, high-frequency oscillatory ventilation (HFOV) has been considered advan-
tageous for maintaining oxygenation using higher mean airway pressure with minimal
risk of complication. During HFOV, tidal volume (Vt) and associated swings in alveolar
pressure are very small [1,2]. HFOV has been used in a variety of clinical situations, in-
cluding neonatal respiratory distress syndrome (RDS), congenital diaphragmatic hernia
(CHD), meconial aspiration syndrome (MAS), air leak syndrome and other [3-5]. HFOV
showed a number of different mechanisms in addition to bulk convection that have been© 2013 Baba et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
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metric velocity profiles, pendelluft, cardiogenic mixing, collateral ventilation and molecu-
lar diffusion [6].
Helium is a noble gas, with very low atomic weight (4 g/mol) and density (0.157 g/L
at 37°C and 1 atm). The density of helium-oxygen mixture reduces the resistance fac-
tor in gas delivery [7]. This increased mobility has three effects: gas more readily
reaches the alveoli, thus allowing greater diffusion; breathing effort is significantly re-
duced by using a less-dense gas; and carbon dioxide is eliminated more rapidly
through a helium-oxygen mixture than through a nitrogen-oxygen mixture [8-10]. In
HFOV with helium, both properties may contribute to improved ventilation [11].
Winters et al. reported a case series of children with respiratory acidosis during
HFOV. When the carrier gas was changed to a helium-oxygen mixture, CO2 clear-
ance improved [12]. Helium-oxygen mixtures have been examined using HFOV in
animal models [9,10,13]. Those experiments showed that the improvement of ventila-
tion with a helium-oxygen mixture was related to a larger Vt delivery by the oscillator
under the same amplitude (AMP). If Vt during HFOV is maintained at a constant
level, use of a helium-oxygen mixture does not alter gas exchange in HFOV ventila-
tors with either a membrane-driven oscillator [10] or a piston-driven oscillator [13].
Continuous tracheal gas insufflation (TGI) is a technique that flushes dead space,
and may thus allow reductions in respiratory support. Kakous et al. [14] reported the
effects of continuous TGI in conventional ventilation. The effect of TGI is based
mainly on the replacement of end-tidal gas in the instrumental dead space with an in-
spiratory gas mixture.
We hypothesized that a helium-oxygen mixture delivered into the trachea using a TGI
technique (0.3 L/min) would enhance CO2 elimination during HFOV. The purpose of
this study was to compare the effects of TGI on gas exchange using helium-oxygen and
nitrogen-oxygen mixtures in a rabbit model during HFOV.Methods
Bench test
To elucidate the physical effects of reducing gas density during HFOV with TGI, we
performed a bench test utilizing a test lung. A schematic of the experimental system
is shown in Figure 1. The test lung (NeoLung; IngMar Medical, PA) was connected to
the endotracheal tube (ETT) with a monitoring lumen (internal diameter, 3.5 mm;
Mallinckrodt, St. Louis, MO), and attached to the circuit of a piston-driven high-
frequency ventilator (Humming II; Metran, Saitama, Japan). Static compliance and re-
sistance of the test lung were1.3 mL/cmH2O/kg and 160 cmH2O/L/s/kg, respectively.
Pressure at the Y-piece of the circuit was monitored using a pressure sensor (AP-C35;
Keyence, Osaka, Japan). The carrier gas (nitrogen-oxygen or helium-oxygen mixture,
78:22 mixture ratio; bias flow rate, 8 L/min) inside the HFOV circuit was oscillated
using the piston-driven Humming II with mean airway pressure set at 12 cmH2O,
stroke volume (SV) at 15 mL, and frequency at 15 Hz.
In the series of HFOV with TGI, the carrier gas inside the HFOV circuit was a
nitrogen-oxygen mixture (78:22 mixture ratio). Insufflating gas flow (nitrogen-oxygen






















Figure 1 Schematic of the experimental system. The carrier gas (nitrogen-oxygen mixture or helium-
oxygen mixture; bias flow rate, 8 L/min) inside the HFOV circuit was oscillated with mean airway pressure
set at 12 cmH2O, stroke volume at 15 mL, and frequency of 15 Hz. Helium-oxygen mixture was supplied at
the O2 port of the ventilator. In the series of HFOV with TGI, insufflating gas flow (nitrogen-oxygen mixture
or helium-oxygen mixture) through the monitoring lumen of the ETT was 0.3 L/min.
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analyzer (PF-300; ImtMedical, Buchs, Switzerland) to ensure that TGI flow of the two
gases was equal. To compare the speed of CO2 transport, 5 ml of tracer gas (CO2)
was injected into the system through an access port near the test lung. CO2 partial
pressure at the end of the ETT was monitored using an EtCO2 monitor (OLG-2800;
Nihon Kohden, Tokyo, Japan). Real-time data from the EtCO2 monitor were collected
using a computerized data accumulation system at a sampling rate of 200 samples/s.
The single exponential curve describing the CO2 concentration inside the system for
3 s was approximated by nonlinear regression (Excel 2010; Microsoft, WA). We used
the equation: measured CO2 concentration = a exp
-b t, where a and b are the variables
obtained by curve fitting and t is the time of CO2 measurement from the point at
which CO2 concentration was 100 mmHg, representing the upper limit of the meas-
urement capability of the EtCO2 monitor. All experiments were repeated six times.Animal preparation
All study protocols were approved by the Institutional Animal Care and Use Commit-
tee of Shinshu University, Nagano, Japan. Three Japanese white rabbits (body weight,
2.309 ± 0.131 kg) were used in the study. Animals were premedicated by intramuscu-
lar administration of midazolam (10 mg/kg/dose) and xylazine (5 mg/kg/dose). The
ear vein was cannulated using a 24-G angiocatheter for intravenous anesthesia and
hydration. Animals were placed in a supine position under a radiant warmer to main-
tain body temperature throughout the entire study period, and body temperature was
Baba et al. BioMedical Engineering OnLine 2013, 12:29 Page 4 of 9
http://www.biomedical-engineering-online.com/content/12/1/29Tmonitored using a rectal temperature probe. Tracheotomy was performed, and a no-cuff
ETT with monitoring lumen (internal diameter, 3.5 mm; Mallinckrodt), was inserted to a
depth of 3 cm from the lower edge of the cricoid cartilage and fixed in place. Intermittent
ventilation (IMV) was initiated using a time-cycled, pressure-limited ventilator (Humming
II; Metran). Using a digital pressure sensor (AP-C40; Keyence) installed into the Y-piece of
the breathing circuit, actual pressure parameters were measured and registered.
Static compliance and resistance were measured by the passive expiratory flow-
volume method, using a pneumotachograph (LFM-317 Aivision Laminar Flow Meter,
Metabo, Lausanne, Switzerland). During this procedure, we confirmed that no leakage
was present. Anesthesia and myoparalysis were provided by continuous intravenous
infusion of midazolam (0.1 mg/kg/h), xylazine (3 mg/kg/h) and pancuronium
(0.1 mg/kg/h). The carotid artery was then cannulated for direct blood pressure meas-
urement, heart rate (HR) monitoring and determination of arterial blood gases
(ABG).
Interventions and measurements
Animals were allowed 20 min for stabilization under IMV. After sustained inflation
maneuver at 20 cmH2O for 10 s, ventilation mode was shifted to the HFOV mode of
the same ventilator (Humming II; Metran). ABG was obtained after 10 min of ventila-
tion with: mean airway pressure (MAP), 12 cmH2O; frequency, 15 Hz; FiO2, 0.30; and
bias flow rate, 8 L/min. SV (same as Vt) was adjusted to 4.16 ± 0.57 ml (mean ± stand-
ard deviation) to obtain permissive hypercapnia. The target PaCO2 was 70 mmHg.
Amplitude (AMP) was a subordinate factor during HFOV with the piston-driven os-
cillator, which was influenced by SV, animal airway condition (especially compliance)
and the nature of the gas in the circuit. After baseline recordings were taken, tracheal
gas was insufflated through the second monitoring lumen of the ETT for 10 min at
gas flow of 0.3 L/min. In our preliminary experiment in healthy rabbits, steady state
was reached after approximately 5 min during HFOV with TGI. After data collection
with a nitrogen-oxygen mixture (70:30 mixture ratio), the gas for TGI was switched




























Figure 2 CO2 elimination curve. The average of CO2 elimination in comparison of nitrogen-oxygen and
helium-oxygen mixtures with or without TGI.
Table 1 Effects of the speed of CO2 transport on the time constant
Insufflating gas Non-linear regression b Time constant = 1/|b|
Helium-oxygen y = 91.641e-0.4848x −0.4848 2.06
y = 91.24e-0.4986x −0.4986 2.01
y = 89.045e-0.4748x −0.4748 2.11
y = 91.327e-0.4936x −0.4936 2.03
y = 93.579e-0.4859x −0.4859 2.06
y = 92.799e-0.492x −0.492 2.03
mean ± SD 2.05 ± 0.04
Nitrogen-oxygen y = 94.984e-0.436x −0.436 2.29
y = 94.806e-0.436x −0.436 2.29
y = 94.334e-0.436x −0.436 2.29
y = 95.175e-0.4367x −0.4367 2.29
y = 93.381e-0.4321x −0.4321 2.31
y = 96.175e-0.437x −0.437 2.29
mean ± SD 2.3 ± 0.01
Bias flow gas Non-linear regression b Time constant = 1/|b|
Helium-oxygen y = 101.18e-0.182x −0.182 5.49
y = 100.9e-0.181x −0.181 5.52
y = 99.006e-0.1774x −0.1774 5.64
y = 100.35e-0.1807x −0.1807 5.53
y = 101.64e-0.1797x −0.1797 5.56
y = 99.601e-0.1771x −0.1771 5.65
mean ± SD 5.57 ± 0.06
Nitrogen-oxygen y = 99.37e-0.1925x −0.1925 5.19
y = 98.925e-0.1801x −0.1801 5.55
y = 100.75e-0.1751x −0.1751 5.71
y = 99.517e-0.1738x −0.1738 5.75
y = 100.72e-0.1733x −0.1733 5.77
y = 96.836e-0.1912x −0.1912 5.23
mean ± SD 5.54 ± 0.26
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oxygen mixture (70:30), the gas for TGI was returned to the nitrogen-oxygen mixture
(70:30), and allowed 10 min to stabilize before data collection. HFOV settings were
held constant while the gas mixture of TGI was changed. The cycle of changing the
gas mixture from nitrogen-oxygen mixture to helium-oxygen mixture and back was
performed three times per animal. To ensure that animal conditions returned to base-
line after each experiment, rabbits were ventilated under HFOV without TGA.
Statistics
Data were analyzed by Wilcoxon t-test, one-way analysis of variance (ANOVA) or
repeated-measures ANOVA, followed by the Bonferroni test to compare matched
experimental sets. All data are presented as mean ± standard error of the mean. Sig-
nificance was defined for values of p < 0.01.
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Bench test
The CO2 elimination curve is shown in Figure 2. Speed of CO2 transport is expressed
as the time for the CO2 concentration to reach 63% of the final concentration (time
constant). Effects of the speed of CO2 transport on the time constant are summarized
in Table 1. When the carrier gas inside the HFOV circuit was changed without TGI,
the time constant was 5.54 ± 0.26 s with the nitrogen-oxygen mixture and 5.57 ± 0.06 s
with the helium-oxygen mixture. When the gas for TGI was changed to a low-density
gas, speed of CO2 transport increased, as reflected by a significant fall in time constant
from 2.3 ± 0.01 s with the nitrogen-oxygen mixture to 2.05 ± 0.04 s with the helium-
oxygen mixture (p < 0.01).Animal experiments
We compared PaCO2 and PaO2 values obtained after 10 min of TGI with each of
the two gas mixtures (Figure 3). Compared with the nitrogen-oxygen mixture, the
helium-oxygen mixture reduced PaCO2 by 7.6 mmHg (p < 0.01) and improved PaO2 by
14 mmHg (p<0.01). AMP during TGI was significantly lower with the helium-oxygen mixture
than with the nitrogen-oxygen mixture (p < 0.01) and did not significantly impact MAP (Table 2).Discussion
Helium may alter gas exchange during HFOV via a number of mechanisms. Because he-
lium is less dense than nitrogen, the frictional forces in turbulent flows are reduced with
helium as compared to oxygen-enriched air. For a given set of airway dimensions, turbu-
lent flow results in a higher resistance than laminar flow. In addition, mechanical ventila-
tion through a narrow ETT and airway, particularly in pediatric and neonatal patients, may
further increase the Reynolds number, thus resulting in greater turbulent flow [15,16]. With
helium, the calculated Reynolds number is lower (<200), which may change regions of tur-
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Figure 3 PaCO2 and PaO2 under TGI. The gas mixture under TGI was changed from nitrogen-oxygen to
helium-oxygen and back.
Table 2 AMP and MAP change during the animal experiment
No TGI TGI N2 + O2 TGI He + O2 TGI N2 + O2 TGI He + O2 TGI N2 + O2 TGI He + O2 TGI N2 + O2 No TGI
Rabbit 1 AMP (cm H2O) 19 19.2 17.4
* 19.5 17.7* 19.3 17.2* 19.2 19.8
Rabbit 2 AMP (cm H2O) 17.5 17.5 15.9
* 17.5 16.1* 17.9 16* 17.6 17.8
Rabbit 3 AMP (cm H2O) 15.8 15.9 14.2
* 16 14.4* 16 14.4* 16.1 16.3
Rabbit I MAP (cm H2O) 12 11.9 11.7 12 11.6 11.8 11.6 11.8 12
Rabbit 2 MAP (cm H2O) 12 12 12.1 12.2 12.1 12.2 12 12.1 12.1
Rabbit 3 MAP (cm H2O) 12.7 12.7 12.7 12.9 12.7 12.9 12.8 12.7 12.8
AMP amplitude, MAP mean air-way pressure, TGI tracheal gas insufflation.
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been confirmed before in a laboratory study [8]. In theory, because of its lower density, he-
lium may favorably alter gas exchange through the pendelluft effect, inhalation/exhalation
flow asymmetry, Taylor dispersion, and molecular diffusion [9].
By flushing dead space, continuous TGI may allow reductions in respiratory support.
The effect of continuous TGI is based mainly on the replacement of end-tidal gas in
the instrumental dead space with an inspiratory gas mixture. Continuous TGI allows
the use of low-volume ventilation over a prolonged period and reduces the duration of
mechanical ventilation in preterm infants [17]. To facilitate CO2 transport without in-
creasing SV and AMP, a helium-oxygen mixture was administered to the turbulent
zone using TGI techniques.
When using a helium-oxygen mixture for TGI, CO2 excretion speed increases under
constant SV. This effect is attributed to the nature of helium in the turbulent zone. A
significant decrease in PaCO2 was shown in animal experiments performed to repro-
duce the effects apparent in the bench test. The concentration of helium in the test
lung that resulted from mixing the TGI flow with the main flow was same as main flow.
When we supplied 0.6 ml/min of TGI flow, helium-oxygen was not needed on the ven-
tilator. We therefore propose that TGI offers a very simple, cost-effective means of sup-
plying helium-oxygen during HFOV, without the need to adapt/calibrate the ventilator
for the use with helium-oxygen and avoiding the high gas consumption associated with
a high bias flow rate.
One limitation of the present study was that our experiment was performed in nor-
mal animal lungs. The low density of helium does not always reduce resistance [18].
Different types and phenotypes of obstructive airway disease manifest in different re-
gions of the lung. The effectiveness of TGI on helium-oxygen mixture HFOV may thus
differ according to the type of obstructive airway disease. Further research using lung
injury models is therefore warranted.Conclusion
This study demonstrated that a helium-oxygen mixture delivered into the trachea using
a tracheal gas insufflation (TGI) technique enhances CO2 elimination and offers a sim-
ple cost-effective means of achieving helium-oxygen mixture HFOV.
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